309
edits
Changes
Jump to navigation
Jump to search
updating references
<!-- This is a very short description of the technology's purpose. What will it be doing, for what goal was it created, how it modifies human cognition. Keep this as brief as possible. -->
Quell wearable is device designated for treatment of chronic pain, nerve deseases and disrupted sleep.<refname="company-overview">Neurometrix, Company overview: http://www.neurometrix.com/about-neurometrix/company-overview.html, (Retrieved Dec 15, 2015)</ref> It works on principle of transcutaneous electrical nerve stimulation, which causes release of endogenous opiates affecting pain relief.
=== Company & People ===
<!-- This is a list of important people behind the technology. Note: It is not necessary to list absolutely everyone. -->
Neurometrix is company directed on developing health-care wearable technology with main effort on sleep disorders, chronical pain, and nerve deseases treatment. The company, having a seat in Waltham Massachusetts, was founded in 1996 as a spinoff of the Harvard-MIT partition of Health Sciences and Technology.<ref>Neurometrix, Company overview: http://www.neurometrix.com/about-neurometrix/name="company-overview.html<"/ref><ref>NeuroMetrix Launches Quell™ Wearable Pain Relief Technology: http://www.businesswire.com/news/home/20150615005489/en/</ref>
Currently Neurometrix offers four products in total:<ref>Neurometrix, Company overview: http://www.neurometrix.com/about-neurometrix/name="company-overview.html<"/ref>
* Quell™ - Wearable device for palliative purpose
Important dates of Quell device history:
* 1996 - Establishment of Neurometrix.<ref>Company overview: http://www.neurometrix.com/about-neurometrix/name="company-overview.html, (Retrieved Dec 15, 2015)<"/ref>
* 2014 - FDA gives a clearance to release Quell wearable device.<ref>NeuroMetrix Begins Shipping Quell Device, June 1, 2015: http://www.fdanews.com/articles/171428 (Retrieved Dec 15, 2015)</ref>
